Skip to main content
All lobbying filings

CGCN Group, LLC

CGCN Group, LLC filed a Q2 report for Vertex Pharmaceuticals Incorporated on July 19, 2026, reporting $50,000 in lobbying income.

Lobbying for Vertex Pharmaceuticals Incorporated · Biopharmaceutical Company

As filed: CGCN GROUP, LLC for VERTEX PHARMACEUTICALS INCORPORATED.

All filings by CGCN Group, LLC · Everything Vertex Pharmaceuticals Incorporated has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 19, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
Massachusetts

Official filing document

 Lobbyists on this filing 1
  • SARAH GILBERT New on this filing
    Previously held: (3) Legislative Correspondent, Rep. George Holding, Nov. 2017-Aug. 2018; Staff Assistant, Rep. George Holding, Dec. 2016-Nov. 2017

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Health Issues

Access to innovative non-opioid medicines.

Medicare/Medicaid

Access to innovative non-opioid medicines; Alternatives to PAIN, H.R. 1227; Alternatives to PAIN, S. 475.

 Bills named in this filing 2

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem